Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_assertion type Assertion NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_head.
- NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_assertion description "[Furthermore, in the haplotype analysis of IL-10 gene, we found that patients carrying ATA haplotype were in higher LN involvement (p = 0.022) and higher tumor stage(p = 0.028) of breast cancer at the time of diagnosis compared with others.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_provenance.
- NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_assertion evidence source_evidence_literature NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_provenance.
- NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_assertion SIO_000772 20553628 NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_provenance.
- NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_assertion wasDerivedFrom befree-2016 NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_provenance.
- NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_assertion wasGeneratedBy ECO_0000203 NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_provenance.